Xylem Inc. (XYL) Stock Forecast
Data as of Jul 31, 2026Industrials · Current price $117.67 (+0.70%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 14, 2026 | Nathan Jones | Stifel Nicolaus | $163.00 | +38.5% |
| Apr 9, 2026 | Joshua Spector | UBS | $152.00 | +29.2% |
| Feb 13, 2026 | Joshua Spector | UBS | $155.00 | +31.7% |
| Jan 7, 2026 | William Grippin | Barclays | $166.00 | +41.1% |
| Jan 5, 2026 | Brett Linzey | Mizuho Securities | $150.00 | +27.5% |
| Oct 29, 2025 | Brett Linzey | Mizuho Securities | $160.00 | +36.0% |
| Oct 29, 2025 | Michael Halloran | Robert W. Baird | $178.00 | +51.3% |
| Oct 29, 2025 | William Grippin | Barclays | $172.00 | +46.2% |
| Aug 13, 2024 | Damian Karas | UBS | $165.00 | +40.2% |
| Jul 31, 2024 | Michael Halloran | Robert W. Baird | $170.00 | +44.5% |
| May 31, 2024 | Bryan Blair | Oppenheimer | $152.00 | +29.2% |
| May 29, 2024 | John Eade | Argus Research | $165.00 | +40.2% |
| May 3, 2024 | Brett Linzey | Mizuho Securities | $135.00 | +14.7% |
| May 3, 2024 | Deane Dray | RBC Capital | $162.00 | +37.7% |
| May 3, 2024 | Michael Halloran | Robert W. Baird | $155.00 | +31.7% |
| Apr 8, 2024 | Brad Hewitt | Wolfe Research | $143.00 | +21.5% |
| Apr 4, 2024 | Deane Dray | RBC Capital | $153.00 | +30.0% |
| Aug 18, 2023 | Nathan Jones | Stifel Nicolaus | $133.00 | +13.0% |
| Nov 16, 2022 | Richard Radbourne | Atlantic Equities | $129.00 | +9.6% |
| Nov 22, 2021 | Scott Graham | Loop Capital Markets | $120.00 | +2.0% |
Top Analysts Covering XYL
XYL vs Sector & Market
| Metric | XYL | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.40 | 2.42 |
| Analyst Count | 23 | 8 | 19 |
| Target Upside | +26.1% | +109.1% | +18.0% |
| P/E Ratio | 29.27 | 36.63 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.12B | $9.19B | $9.27B | 17 |
| 2027-03-31 | $2.15B | $2.17B | $2.22B | 6 |
| 2027-06-30 | $2.39B | $2.42B | $2.47B | 6 |
| 2027-09-30 | $2.37B | $2.40B | $2.45B | 6 |
| 2027-12-31 | $2.52B | $2.55B | $2.60B | 6 |
| 2028-03-31 | $2.25B | $2.28B | $2.33B | 5 |
| 2028-06-30 | $2.51B | $2.55B | $2.60B | 5 |
| 2028-09-30 | $2.49B | $2.52B | $2.57B | 6 |
| 2028-12-31 | $2.64B | $2.67B | $2.73B | 8 |
| 2029-12-31 | $10.43B | $10.63B | $10.88B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5.42 | $5.48 | $5.57 | 14 |
| 2027-03-31 | $1.16 | $1.18 | $1.21 | 10 |
| 2027-06-30 | $1.46 | $1.48 | $1.52 | 6 |
| 2027-09-30 | $1.56 | $1.59 | $1.63 | 7 |
| 2027-12-31 | $1.68 | $1.71 | $1.76 | 6 |
| 2028-03-31 | $1.30 | $1.32 | $1.36 | 7 |
| 2028-06-30 | $1.56 | $1.58 | $1.63 | 7 |
| 2028-09-30 | $1.68 | $1.71 | $1.75 | 12 |
| 2028-12-31 | $1.81 | $1.84 | $1.89 | 7 |
| 2029-12-31 | $7.52 | $7.71 | $7.94 | 2 |
Frequently Asked Questions
What is the analyst consensus for XYL?
The consensus among 23 analysts covering Xylem Inc. (XYL) is Buy with an average price target of $150.13.
What is the highest price target for XYL?
The highest price target for XYL is $178.00, set by Michael Halloran at Robert W. Baird on 2025-10-29.
What is the lowest price target for XYL?
The lowest price target for XYL is $107.00, set by Brian K. Lee at Goldman Sachs on 2021-05-05.
How many analysts cover XYL?
23 analysts have issued ratings for Xylem Inc. in the past 12 months.
Is XYL a buy or sell right now?
Based on 23 analyst ratings, XYL has a consensus rating of Buy (2.17/5) with a +26.1% upside to the consensus target of $150.13.
What are the earnings estimates for XYL?
Analysts estimate XYL will report EPS of $5.48 for the period ending 2026-12-31, with revenue estimated at $9.19B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.